President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.| BioSpace
The move comes after President Donald Trump warned Big Pharma leaders that he would impose tariffs on them if they refuse to reshore their manufacturing operations.| BioSpace
Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Pfizer has also promised a similar commitment.| BioSpace
Follow along as BioSpace tracks job cuts and restructuring initiatives.| BioSpace